Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/ProPhase Labs, Inc./ NT 10-Q

SEC Filing · NT 10-Q

ProPhase Labs, Inc.

PRPHOTCEQUITYCurrent

SEC Filing

Filed Aug 14, 2026Accepted Aug 14, 2026, 4:30 PM EDTCIK 868278Accession 0001493152-26-038433
View company →Permanent SEC source ↗
Share

Company context

We are a next-generation biotech, genomics and consumer products company. We are also focused on licensing, developing and commercializing novel drugs, dietary supplements, compounds, and diagnostics.

Current securities

PRPHOTC · EQUITY · Current

Recent company filings

  1. 10-Q filingAug 19, 2026
  2. Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementAug 6, 2026
  3. 10-Q/A filingJul 9, 2026
  4. 10-Q/A filingJul 7, 2026
  5. 10-Q filingJun 30, 2026

As-filed source

Primary evidence
As filedOpen full document ↗